UBS Group’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Sell |
13,206
-17,912
| -58% | -$186K | ﹤0.01% | 5727 |
|
|
2025
Q1 | $410K | Buy |
31,118
+13,538
| +77% | +$178K | ﹤0.01% | 4814 |
|
|
2024
Q4 | $315K | Buy |
17,580
+12,241
| +229% | +$219K | ﹤0.01% | 4999 |
|
|
2024
Q3 | $86.1K | Buy |
5,339
+3,102
| +139% | +$50K | ﹤0.01% | 5272 |
|
|
2024
Q2 | $60.4K | Sell |
2,237
-115,189
| -98% | -$3.11M | ﹤0.01% | 5399 |
|
|
2024
Q1 | $76.3K | Sell |
117,426
-14,338
| -11% | -$9.32K | ﹤0.01% | 5176 |
|
|
2023
Q4 | $90.8K | Buy |
131,764
+71,464
| +119% | +$49.2K | ﹤0.01% | 5030 |
|
|
2023
Q3 | $63.9K | Sell |
60,300
-3,313
| -5% | -$3.51K | ﹤0.01% | 5006 |
|
|
2023
Q2 | $71.2K | Buy |
+63,613
| New | +$71.2K | ﹤0.01% | 5203 |
|
|
2022
Q4 | – | Sell |
-11,102
| Closed | -$18K | – | 9758 |
|
|
2022
Q3 | $18K | Buy |
+11,102
| New | +$18K | ﹤0.01% | 6443 |
|
|
2022
Q2 | – | Sell |
-1,171
| Closed | -$1K | – | 9653 |
|
|
2022
Q1 | $1K | Sell |
1,171
-24,121
| -95% | -$20.6K | ﹤0.01% | 8852 |
|
|
2021
Q4 | $82K | Sell |
25,292
-124,343
| -83% | -$403K | ﹤0.01% | 5405 |
|
|
2021
Q3 | $622K | Buy |
149,635
+143,910
| +2,514% | +$598K | ﹤0.01% | 3583 |
|
|
2021
Q2 | $24K | Sell |
5,725
-292,074
| -98% | -$1.22M | ﹤0.01% | 6058 |
|
|
2021
Q1 | $1.35M | Buy |
297,799
+297,699
| +297,699% | +$1.35M | ﹤0.01% | 3089 |
|
|
2020
Q4 | $0 | Sell |
100
-283
| -74% | – | ﹤0.01% | 7578 |
|
|
2020
Q3 | $1K | Sell |
383
-31,488
| -99% | -$82.2K | ﹤0.01% | 6940 |
|
|
2020
Q2 | $91K | Buy |
+31,871
| New | +$91K | ﹤0.01% | 4550 |
|
|
2019
Q4 | – | Sell |
-3,895
| Closed | -$7K | – | 7154 |
|
|
2019
Q3 | $7K | Buy |
3,895
+3,871
| +16,129% | +$6.96K | ﹤0.01% | 6378 |
|
|
2019
Q2 | $0 | Sell |
24
-91
| -79% | – | ﹤0.01% | 7112 |
|
|
2019
Q1 | $0 | Sell |
115
-10,829
| -99% | – | ﹤0.01% | 7068 |
|
|
2018
Q4 | $29K | Buy |
10,944
+2,799
| +34% | +$7.42K | ﹤0.01% | 5599 |
|
|
2018
Q3 | $126K | Buy |
8,145
+4,552
| +127% | +$70.4K | ﹤0.01% | 4531 |
|
|
2018
Q2 | $48K | Buy |
3,593
+773
| +27% | +$10.3K | ﹤0.01% | 5095 |
|
|
2018
Q1 | $29K | Sell |
2,820
-330
| -10% | -$3.39K | ﹤0.01% | 5257 |
|
|
2017
Q4 | $31K | Buy |
3,150
+416
| +15% | +$4.09K | ﹤0.01% | 5242 |
|
|
2017
Q3 | $50K | Buy |
2,734
+508
| +23% | +$9.29K | ﹤0.01% | 4911 |
|
|
2017
Q2 | $44K | Sell |
2,226
-69,135
| -97% | -$1.37M | ﹤0.01% | 4832 |
|
|
2017
Q1 | $1.02M | Buy |
71,361
+65,938
| +1,216% | +$944K | ﹤0.01% | 2819 |
|
|
2016
Q4 | $93K | Sell |
5,423
-5,093
| -48% | -$87.3K | ﹤0.01% | 4459 |
|
|
2016
Q3 | $149K | Sell |
10,516
-286,218
| -96% | -$4.06M | ﹤0.01% | 3916 |
|
|
2016
Q2 | $4.15M | Buy |
+296,734
| New | +$4.15M | ﹤0.01% | 1635 |
|